SRRA
Sierra Oncology, Inc. Common Stock
SRRA
SRRA
Delisted
SRRA was delisted on the 30th of June, 2022.
61 hedge funds and large institutions have $64M invested in Sierra Oncology, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
64% less call options, than puts
Call options by funds: $30K | Put options by funds: $83K
Holders
61
Holding in Top 10
2
Calls
$30K
Puts
$83K
Top Buyers
| 1 | +$4.23M | |
| 2 | +$2.64M | |
| 3 | +$2.11M | |
| 4 |
BC
Broadfin Capital
New York
|
+$1.04M |
| 5 |
6CM
683 Capital Management
New York
|
+$493K |
Top Sellers
| 1 | -$1.79M | |
| 2 | -$1.01M | |
| 3 | -$834K | |
| 4 |
PA
Perceptive Advisors
New York
|
-$683K |
| 5 |
Renaissance Technologies
New York
|
-$585K |